164 related articles for article (PubMed ID: 30703105)
1. Current management of cervical cancer in Poland-Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations.
Basta T; Knapp P; Blecharz P; Bodnar L; Gawron I; Babczyk D; Piróg M; Kluz T; Markowska A; Horbaczewska A; Jach R
PLoS One; 2019; 14(1):e0209901. PubMed ID: 30703105
[TBL] [Abstract][Full Text] [Related]
2. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
[TBL] [Abstract][Full Text] [Related]
3. The effect of the population-based cervical cancer screening program on 5-year survival in cervical cancer patients in Lower Silesia.
Zielecka-Dębska D; Błaszczyk J; Błaszczyk D; Szelachowska J; Lichoń K; Maciejczyk A; Matkowski R
Adv Clin Exp Med; 2019 Oct; 28(10):1377-1383. PubMed ID: 31638746
[TBL] [Abstract][Full Text] [Related]
4. Survival in women diagnosed with breast and cervical cancer in Poland – compared to European countries, based on CONCORD - 3 Programme.
Gliniewicz A; Zielińska A; Kwiatkowska K; Dudek-Godeau D; Bielska–Lasota M
Przegl Epidemiol; 2018; 72(4):499-508. PubMed ID: 30810005
[TBL] [Abstract][Full Text] [Related]
5. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
Fujiwara M; Isohashi F; Mabuchi S; Yoshioka Y; Seo Y; Suzuki O; Sumida I; Hayashi K; Kimura T; Ogawa K
J Radiat Res; 2015 Mar; 56(2):305-14. PubMed ID: 25428244
[TBL] [Abstract][Full Text] [Related]
7. Computed Tomography-Planned High-Dose-Rate Brachytherapy for Treating Uterine Cervical Cancer.
Zolciak-Siwinska A; Gruszczynska E; Bijok M; Jonska-Gmyrek J; Dabkowski M; Staniaszek J; Michalski W; Kowalczyk A; Milanowska K
Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):87-92. PubMed ID: 27375169
[TBL] [Abstract][Full Text] [Related]
8. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
[TBL] [Abstract][Full Text] [Related]
9. Equivalent survival in patients with advanced stage IB-II and III-IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy.
Carcopino X; Houvenaeghel G; Buttarelli M; Esterni B; Tallet A; Goncalves A; Jacquemier J
Eur J Surg Oncol; 2008 May; 34(5):569-75. PubMed ID: 17531428
[TBL] [Abstract][Full Text] [Related]
10. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
11. Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting.
Jung PS; Kim DY; Lee SW; Park JY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
PLoS One; 2015; 10(7):e0132298. PubMed ID: 26176626
[TBL] [Abstract][Full Text] [Related]
12. [Results of cervical cancer treatment at the Lower Silesian Oncology Center between 1987 and 1989].
Dryl J
Ginekol Pol; 2002 Dec; 73(12):1184-91. PubMed ID: 12722466
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant intensity-modulated radiotherapy (IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors: A phase II trial.
Wang X; Shen Y; Zhao Y; Li Z; Gou H; Cao D; Yang Y; Qiu M; Li Q; Liu J; Yi C; Liao Z; Luo D; Xu F; Bi F
Eur J Surg Oncol; 2015 Aug; 41(8):1082-8. PubMed ID: 26033265
[TBL] [Abstract][Full Text] [Related]
14. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
[TBL] [Abstract][Full Text] [Related]
15. [Influence of tumor diameter on treatment results in cervical cancer patients].
Jońska-Gmyrek J; Zółciak-Siwińska A; Gmyrek L; Staniaszek J; Lindner B; Andrzejuk J
Ginekol Pol; 2012 Aug; 83(8):576-80. PubMed ID: 23342879
[TBL] [Abstract][Full Text] [Related]
16. Special Focus on Stage IV Cervical Cancer Patients: A Decade Experience.
Espenel S; Garcia MA; Langrand-Escure J; Vallard A; Trone JC; Rancoule C; Vial N; Moreno-Acosta P; Chauleur C; Boutet C; Peoc Apos H M; Prevot-Bitot N; Guy JB; Magné N
Oncology; 2019; 97(3):125-134. PubMed ID: 31266037
[TBL] [Abstract][Full Text] [Related]
17. Clinico-morphological parameters affecting survival of patients with advanced cervical cancer.
Klimek M; Kruczak A; Ryś J; Mularz K; Halaszka K; Przewoźnik M; Moskal J; Sokołowski A; Urbański K
Pol J Pathol; 2011 Dec; 62(4):250-6. PubMed ID: 22246911
[TBL] [Abstract][Full Text] [Related]
18. Overall survival (OS) in patients after chemotherapy for cervical cancer in Poland in years 2008-2015.
Wierzba W; Jankowski M; Placiszewski K; Ciompa P; Jakimiuk AJ; Danska-Bidzinska A
Ginekol Pol; 2022; 93(7):540-545. PubMed ID: 35072222
[TBL] [Abstract][Full Text] [Related]
19. Investigation of uterine arterial chemoembolization and uterine arterial infusion chemotherapy for advanced cervical cancer before radical radiotherapy: a long-term follow-up study.
Tian ZZ; Li S; Wang Y; Yue YJ; Zhu XH; Zhao R; Zhang CL; Wei SH
Arch Gynecol Obstet; 2014 Jul; 290(1):155-62. PubMed ID: 24573504
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
